Actively Recruiting
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
Led by Mayo Clinic · Updated on 2025-12-16
400
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
CONDITIONS
Official Title
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients aged 2-7 years
- Surgeries include ENT cases (tonsillectomy/adenoidectomy), ophthalmology cases (strabismus), and urology cases
- Procedures can be outpatient or General Care inpatient
- All cases must include an intravenous line and an endotracheal tube
You will not qualify if you...
- Severe developmental or cognitive delay preventing eye contact, verbal communication, or interaction needed for assessment
- Total intravenous anesthesia (TIVA) cases
- No peripheral intravenous line during surgery or planned postoperative ICU admission
- Previous documented history of severe emergence delirium
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
L
Lindsay Warner, MD
CONTACT
M
Molly Herr, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here